News
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
Merck KGaA discontinues phase III trials of xevinapant in locally advanced head & neck cancer after interim analysis results. Xevinapant is currently under clinical investigation -
COMMUNIQUÉ DE PRESSE
PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 17 JUIN 2024 au 21 JUIN 2024
Déclaration des transactions sur actions propres de Patrimoine et Commerce du 17 au 21 juin 2024. Reporting détaillé disponible sur www.patrimoine-commerce.com -
COMMUNIQUÉ DE PRESSE
The Diabetes Research Institute, University of Miami, Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024
iTolerance Inc. announces breakthrough results with innovative approach combining human stem cell-derived islets and immunomodulatory microgel to reverse Type 1 Diabetes, presented at ADA's 84th Scientific Sessions -
-
COMMUNIQUÉ DE PRESSE
Weather Shield Roofing Systems and Great Lakes Systems Announce Strategic Merger to Enhance Services and Expand Reach
Weather Shield Roofing Systems and Great Lakes Systems have merged to broaden service offerings and create new employee opportunities. The strategic move aims to enhance capabilities and provide a wider range of solutions for commercial roofing needs -
-
-
-
